Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease

Shilpa ChitnisDepartment of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, Texas, USACorrespondence[email protected]

Manall JafferySTARS Program, UT Southwestern Medical Center, Dallas, Texas, USA and Freshman, Southern Methodist University (SMU), Dallas, Texas, USA

Richard B. Dewey Jr.Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, Texas, USA

REFERENCES

Giladi, N., Boroojerdi, B., Korczyn, A. D., Burn, D. J., Clarke, C. E., Schapira, A. H., (2007). Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole. Movement Disorders, 22, 2398–2404.
PubMed Web of Science ®Google Scholar
Jenner, P. (2005). A novel dopamine agonist for the transdermal treatment of Parkinson's disease. Neurology, 65, S3–S5.
PubMedGoogle Scholar
O'Suilleabhain, P. E., & Dewey, R. B., Jr. (2002). Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Archives of Neurology, 59, 986–989.
PubMed Web of Science ®Google Scholar
Steiger, M. (2008). Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: A new treatment paradigm in Parkinson's disease. European Journal of Neurology, 15, 6–15.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date